• Thu, January 2, 2020
  • Fri, January 3, 2020
  • Mon, December 30, 2019
  • Tue, December 31, 2019

David Amsellem Maintained (BHC) at Buy with Increased Target to $39 on, Dec 30th, 2019

David Amsellem of Piper Sandler, Maintained "Bausch Health Companies Inc." (BHC) at Buy with Increased Target from $30 to $39 on, Dec 30th, 2019.

David has made no other calls on BHC in the last 4 months.



There are 2 other peers that have a rating on BHC. Out of the 2 peers that are also analyzing BHC, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Chris Schott of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $38 on, Thursday, December 12th, 2019
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019